Skip to content

radiomics study on interstitial cystitis/bladder pain syndrome

Research on digital image analysis technology for cystoscopy in the clinical diagnosis of interstitial cystitis/bladder pain syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076181
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-09-27
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial cystitis/bladder pain syndrome

Interventions

Gold Standard:The basic assessment should include a careful history, physical examination, and laboratory examination to document symptoms and signs that characterize IC/BPS and exclude other disorder
Index test:Artificial intelligence diagnostic system for cystoscopy images

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1: The clinical diagnosis is interstitial cystitis/bladder pain syndrome, and the main symptomatologic diagnosis covers pain with bladder filling, which is located mainly in the bladder area (lower abdomen) and relieves after urination. It is characterized by pain (including cramping and discomfort) that occurs with bladder filling and radiates to the pelvic organs such as the urethra, perineum, vagina, rectum, and areas such as the lower abdomen or back of the shoulders 2: Patients with a clinical diagnosis of bladder tumor 3: Age=18 years old 4: Volunteer to participate in research projects and sign informed consent forms 5: Able to communicate well with researchers and willing to comply with the entire experimental requirements

Exclusion criteria

Exclusion criteria: 1: Symptom relief after antimicrobial treatment 2: Comorbidities such as uncontrolled urinary tract infections, urinary tract obstruction, other tumors of the urinary tract, and other serious conditions 3: Chemical cystitis (such as cyclophosphamide) 4: Tuberculous cystitis 5: Radiation cystitis 6: Pregnant and lactating women 7: Participants in other clinical trials in the 3 months prior to the trial 8: Those with Mental disorder who cannot cooperate with doctors 9: Other situations where the researcher deems it inappropriate to participate in the study

Design outcomes

Primary

MeasureTime frame
Cystoscopic images - bladder hemorrhagic spot density;Cystoscopic images-Hunner's ulcer density;Bladder hydrodistention- maximum bladder capacity;accuracy;sensitivity;specificity;area under curve, AUC;

Countries

China

Contacts

Public ContactYaoguang Zhang

Beijing Hospital

zhang003887@sina.com+86 130 3109 9662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026